(Q34628997)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21543987%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Cardiovascular abnormalities in late-onset Pompe disease and response to enzyme replacement therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21543987%20AND%20SRC:MED&resulttype=core&format=json

enzyme replacement therapy

30 January 2020

main subject

0 references

circulatory system

1 reference

cardiovascular abnormality

inferred from title

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21543987%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

5

Priya Kishnani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21543987%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Jennifer S Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21543987%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

P Brian Smith

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21543987%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Ans T van der Ploeg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21543987%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Sara K Pasquali

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21543987%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Late-Onset Treatment Study Investigators

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21543987%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

language of work or name

English

0 references

publication date

1 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21543987%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21543987%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21543987%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21543987%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

625-631

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21543987%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1097/gim.0b013e3182142966

30 January 2020

exact match

0 references

cites work

A randomized study of alglucosidase alfa in late-onset Pompe's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

Cardiac remodeling after enzyme replacement therapy with acid alpha-glucosidase for infants with Pompe disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

Pompe disease diagnosis and management guideline.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

Pompe disease in infants and children

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

Prevalences of ECG findings in large population based samples of men and women

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

Infantile acid maltase deficiency. I. Muscle fiber destruction after lysosomal rupture

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

The spectrum and diagnosis of acid maltase deficiency.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

Pompe's disease presenting as hypertrophic myocardiopathy with Wolff-Parkinson-White syndrome

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease

7 July 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182142966

Disease severity in children and adults with Pompe disease related to age and disease duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182142966

Cardiac involvement in adults with Pompe disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182142966

Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182142966

Recombinant human alpha-glucosidase from rabbit milk in Pompe patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182142966

Reversal of cardiac dysfunction after enzyme replacement in patients with infantile-onset Pompe disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182142966

Glycogen storage disease type II (Pompe disease)--influence of enzyme replacement therapy in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182142966

Electrocardiographic response to enzyme replacement therapy for Pompe disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182142966

Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182142966

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138812

Late onset Pompe disease: Clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients

26 October 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182142966

Clinical features of late-onset Pompe disease: a prospective cohort study

21 January 2018

1 reference

12 December 2020

Cardiac evaluation in children and adults with Pompe disease sharing the common c.-32-13T>G genotype rarely reveals abnormalities

1 reference

12 December 2020

Improvement with ongoing Enzyme Replacement Therapy in advanced late-onset Pompe disease: A case study

1 reference

12 December 2020

[Familial hypertrophic cardiomyopathy associated with Wolff-Parkinson-White syndrome revealing type II glycogenosis]

1 reference

12 December 2020

The conduction system in Pompe's disease

1 reference

12 December 2020

[WPW syndrome combined with AV block 2 in an adult with glycogenosis (Type II)]

1 reference

12 December 2020

The pattern of involvement of adult-onset acid maltase deficiency at autopsy

1 reference

12 December 2020

Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease

1 reference

12 December 2020

Ambulatory electrocardiogram analysis in infants treated with recombinant human acid alpha-glucosidase enzyme replacement therapy for Pompe disease

1 reference

12 December 2020

10.1097/GIM.0B013E3182142966

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21543987%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

30 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21543987%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

PubMed publication ID

21543987

1 reference